HEALTH

AKRON, Ohio — GoJo Industries on Friday announced the acquisition of Laboratoires Prodene Klint. Based in France, Prodene Klint specializes in professional hygiene, cosmetics and disinfectant products.  

Terms of the transaction were not disclosed. 

ZURICH — Bain & Co. released findings Thursday from an online survey of 1,200 people living in New York, Munich and New Delhi that found most would readily trade premium medical care for access to healthier living options, such as more nutritious food, health education, exercise and innovative healthcare technologies.

DENVER — UrgentRx on Thursday began asking America where they would #WhipItOut with the launch of a provocative new campaign. The initiative is aimed at educating consumers during Heart Health Month by raising awareness around the potentially life-saving role that 325mg of aspirin plays for heart attack victims.

BASEL, Switzerland — Novartis Consumer Health will be relaunching Theraflu for the 2014-2015 cough-cold season, Brian McNamara, Novartis division head OTC, told analysts Wednesday. 

"As you know, in the U.S. business we launched Lamisil and Triaminic and Excedrin end of 2012 and 2013. About halfway through the year, we launched Benefiber. And for next year, we expect to launch Theraflu for that cough and cold season," he said. 

CAMP HILL, Pa. — Rite Aid's January same-store sales increased 1.8%, beating out an analyst projection of a 0.5% increase in overall comparable-store sales. Total drug store sales for the four weeks ended Jan. 25 increased 1.5% to $1.9 billion.

January front-end same-store sales decreased 1.3%, of which 1.4% was attributable to a decrease in sales of flu-related over-the-counter products. Pharmacy same-store sales, which included an approximate 124 basis points negative impact from new generic introductions, increased 3.2%. 

LAKE FOREST, Ill. — Omron Healthcare on Tuesday announced the release of its new Pain Relief Pro electroTHERAPY unit. Its versatility delivers more settings and more power for more relief with 10 power levels and eight pre-set modes.

SILVER SPRING, Md. — A pair of Food and Drug Administration advisory committees will be meeting Feb. 10 to talk about heart risks associated with use of NSAIDs and whether or not Bayer's Aleve (naproxen) carries a lower risk profile than other NSAIDs. The FDA is also considering potentially revoking OTC status of certain nonprescription NSAIDS, according to published reports.